From the King Kong of weight-loss jabs to the Godzilla of the category, the GLP-1 industry is undergoing big changes ...

The new 12-month project extends a prior two-year award for which Habegger studied mechanisms of glucagon, Glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) and ...

The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in ...

Intravenous high‐dose glucagon is a recommended antidote against beta‐blocker poisonings, but clinical effects are unclear. We therefore investigated hemodynamic effects and safety of high‐dose ...

Heart failure and cognitive impairment emerge as public health problems that need to be addressed due to the aging global population. The conditions that often coexist are strongly related to ...

Department of Clinical Pharmacology, , Bispebjerg Hospital, , University of Copenhagen, , Copenhagen, , Denmark Department of Clinical Medicine, , Faculty of Health ...

Baqsimi (glucagon) is a prescription drug that’s used to treat severely low blood sugar levels. The drug comes as nasal powder. It’s usually given as a one-time dose. Baqsimi is used in adults and ...

The FDA has cleared IND applications for UBT-251 injection, a long-acting triple-targeted glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP)/glucagon receptor agonist ...

Saxenda (liraglutide) is a prescription drug used for weight management. The drug comes as a liquid solution that you inject daily. Saxenda is used in adults and some children to help with weight loss ...

Saxenda (liraglutide) is a brand-name drug prescribed for weight management in adults and some children. Saxenda comes as an injection pen that’s typically used once per day. Your doctor will ...